Drs. Nimesh Patel (Harvard) and Nicolas A. Yannuzzi (University of Miami) share their insights into the DRCR Retina Networks Protocol AC study of the relative efficacy of administering aflibercept monotherapy as compared to bevacizumab first with a switch to aflibercept if the eye condition does not improve sufficiently.
view more